PT100978A - Peptidos recombitopos, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem e seu uso - Google Patents

Peptidos recombitopos, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem e seu uso

Info

Publication number: PT100978A
Authority: PT; Portugal
Prior art keywords: peptides; protein; therapeutic compositions; recombitope peptides; recombitopos
Prior art date: 1991-10-16

Application number

PT100978A

Other languages

English (en)

Other versions

PT100978B (pt

Inventor

Bruce L Rogers

Jay P Morgenstern

Julian F Bond

Richard D Garman

Julia L Greenstein

Mei-Chang Kuo

Malcom Morville

Original Assignee

Immulogic Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-16

Filing date

1992-10-16

Publication date

1994-01-31

1991-12-13 Priority claimed from US07/807,529 external-priority patent/US5547669A/en

1992-10-16 Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp

1994-01-31 Publication of PT100978A publication Critical patent/PT100978A/pt

1999-10-29 Publication of PT100978B publication Critical patent/PT100978B/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Insects & Arthropods (AREA)
Tropical Medicine & Parasitology (AREA)
Wood Science & Technology (AREA)
Pulmonology (AREA)
Pharmacology & Pharmacy (AREA)
Botany (AREA)
General Physics & Mathematics (AREA)
Plant Pathology (AREA)
Physiology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pathology (AREA)
Animal Behavior & Ethology (AREA)

PT100978A 1991-10-16 1992-10-16 Peptidos recombitope, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem, processo para a sua concepcao e sue uso. PT100978B (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US77785991A	1991-10-16	1991-10-16
US07/807,529 US5547669A (en)	1989-11-03	1991-12-13	Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I

Publications (2)

Publication Number	Publication Date
PT100978A true PT100978A (pt)	1994-01-31
PT100978B PT100978B (pt)	1999-10-29

Family

ID=27119373

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT100978A PT100978B (pt)	1991-10-16	1992-10-16	Peptidos recombitope, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem, processo para a sua concepcao e sue uso.

Country Status (15)

Country	Link
EP (1)	EP0610335B1 (pt)
JP (1)	JP4246794B2 (pt)
KR (1)	KR100271417B1 (pt)
AT (1)	ATE382699T1 (pt)
AU (1)	AU682658B2 (pt)
CA (1)	CA2121498C (pt)
DK (1)	DK0610335T3 (pt)
ES (1)	ES2300100T3 (pt)
FI (1)	FI109809B (pt)
HU (1)	HU227959B1 (pt)
IL (1)	IL103456A (pt)
NO (1)	NO316073B1 (pt)
NZ (2)	NZ299122A (pt)
PT (1)	PT100978B (pt)
WO (1)	WO1993008280A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6120769A (en) *	1989-11-03	2000-09-19	Immulogic Pharmaceutical Corporation	Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
US6019972A (en)	1989-11-03	2000-02-01	Immulogic Pharmaceutical Corporation	Peptides of human T cell reactive feline protein (TRFP)
IL105153A (en) *	1992-03-25	1999-12-22	Immulogic Pharma Corp	Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
US6759234B1 (en) *	1994-09-02	2004-07-06	Immulogic Pharmaceutical Corporation	Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
WO1997032600A1 (fr) *	1996-03-10	1997-09-12	Meiji Milk Products Co., Ltd.	Agent immunotherapeutique a base peptidique pour le traitement des allergies
US6737406B1 (en)	1996-03-21	2004-05-18	Circassia, Ltd.	Cryptic peptides and method for their identification
NZ333431A (en) *	1996-05-24	2000-05-26	Chiron Corp	Multiple epitope fusion protein selected from HIV or HCV, method of immunoassay and assay device
US6514731B1 (en)	1996-05-24	2003-02-04	Chiron Corporation	Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
JP4176750B2 (ja) *	1996-06-14	2008-11-05	明治乳業株式会社	Ｔ細胞エピトープペプチド
CN101307095A (zh) *	1996-06-14	2008-11-19	明治乳业株式会社	T细胞表位肽
IL132611A0 (en) *	1999-10-27	2001-03-19	Yeda Res & Dev	Synthetic genes and polypeptides and pharmaceutical compositions comprising them
AUPQ776100A0 (en)	2000-05-26	2000-06-15	Australian National University, The	Synthetic molecules and uses therefor
EP1221317A1 (en)	2000-12-28	2002-07-10	SHAN-Beteiligungsgesellschaft m.b.H.	Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
RU2188032C1 (ru) *	2001-02-07	2002-08-27	Цепелев Виктор Львович	Средство, стимулирующее дифференцировку т-лимфоцитов
EP1440979B1 (en) *	2003-01-21	2005-10-19	BIOMAY Produktions- und Handels- Aktiengesellschaft	Process for the preparation of hypoallergenic mosaic proteins
AT503690A1 (de) *	2006-06-09	2007-12-15	Biomay Ag	Hypoallergene moleküle
GB2455108A (en) *	2007-11-28	2009-06-03	Circassia Ltd	T-Cell dependent method for detecting non-allergic or intrinsic disorders
BR112016011930A2 (pt)	2013-12-23	2017-09-26	Alk Abello As	combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira
CN117069865B (zh) *	2023-10-12	2024-03-01	中国农业科学院饲料研究所	一种基于T细胞抗原表位猫过敏原蛋白嵌合肽cFel d 1的原核表达及其卵黄抗体的制备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2013359A6 (es) *	1988-11-04	1990-05-01	Corporacion Biolog Farmaceutic	Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
ES2174822T3 (es) *	1989-11-03	2002-11-16	Immulogic Pharma Corp	Una proteina felina reactiva con celulas t humanas (trfp) aislada de polvo domestico y usos para la misma.
DE69131131T2 (de) *	1990-09-11	1999-10-14	Institute For Child Health Research	Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)

1992
- 1992-10-16 IL IL103456A patent/IL103456A/en not_active IP Right Cessation
- 1992-10-16 DK DK92922494T patent/DK0610335T3/da active
- 1992-10-16 PT PT100978A patent/PT100978B/pt not_active IP Right Cessation
- 1992-10-16 JP JP50774893A patent/JP4246794B2/ja not_active Expired - Lifetime
- 1992-10-16 NZ NZ299122A patent/NZ299122A/en not_active IP Right Cessation
- 1992-10-16 EP EP92922494A patent/EP0610335B1/en not_active Expired - Lifetime
- 1992-10-16 HU HU9401109A patent/HU227959B1/hu unknown
- 1992-10-16 KR KR1019940701294A patent/KR100271417B1/ko not_active Expired - Lifetime
- 1992-10-16 NZ NZ244782A patent/NZ244782A/en not_active IP Right Cessation
- 1992-10-16 CA CA002121498A patent/CA2121498C/en not_active Expired - Lifetime
- 1992-10-16 AT AT92922494T patent/ATE382699T1/de active
- 1992-10-16 ES ES92922494T patent/ES2300100T3/es not_active Expired - Lifetime
- 1992-10-16 WO PCT/US1992/008694 patent/WO1993008280A1/en not_active Ceased
- 1992-10-16 AU AU27940/92A patent/AU682658B2/en not_active Expired
1994
- 1994-04-15 NO NO19941370A patent/NO316073B1/no not_active IP Right Cessation
- 1994-04-15 FI FI941758A patent/FI109809B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL103456A (en)	2006-06-11
AU682658B2 (en)	1997-10-16
FI941758L (fi)	1994-06-16
NO941370D0 (no)	1994-04-15
JP4246794B2 (ja)	2009-04-02
AU2794092A (en)	1993-05-21
FI941758A0 (fi)	1994-04-15
ES2300100T3 (es)	2008-06-01
HUT70263A (en)	1995-09-28
NO316073B1 (no)	2003-12-08
NZ244782A (en)	1996-12-20
FI109809B (fi)	2002-10-15
JPH07503362A (ja)	1995-04-13
NO941370L (no)	1994-06-08
CA2121498A1 (en)	1993-04-29
ATE382699T1 (de)	2008-01-15
WO1993008280A1 (en)	1993-04-29
HU9401109D0 (en)	1994-07-28
NZ299122A (en)	2005-02-25
EP0610335B1 (en)	2008-01-02
IL103456A0 (en)	1993-03-15
EP0610335A1 (en)	1994-08-17
KR100271417B1 (ko)	2000-12-01
CA2121498C (en)	2009-02-17
HU227959B1 (en)	2012-07-30
PT100978B (pt)	1999-10-29
DK0610335T3 (da)	2008-04-28

Legal Events

Date	Code	Title	Description
1994-01-31	BB1A	Laying open of patent application	Effective date: 19930630
1999-10-29	FG3A	Patent granted, date of granting	Effective date: 19990715
2007-01-31	PC4A	Transfer of assignment	Owner name: HESKA CORPORATION, US Effective date: 20061205
2007-01-31	TE4A	Change of address (patent)	Owner name: HESKA CORPORATION, US Effective date: 20061207
2007-07-17	PC4A	Transfer of assignment	Owner name: MERCK PATENT GMBH, DE Effective date: 20070703
2014-07-23	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140715

Publication	Publication Date	Title
PT100978A (pt)	1994-01-31	Peptidos recombitopos, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem e seu uso
Hoffman	1977	Allergens in bee venom: III. Identification of allergen B of bee venom as an acid phosphatase
PT100979A (pt)	1994-01-31	Epitopos de celula t dos alergenos principais de dermatophagoides (acaro do po domestico), peptidos modificados, sequencias de acidos nucleicos que os codificam, composicoes farmaceuticas que os contem e seu uso
ATE128627T1 (de)	1995-10-15	Immunomodulare mittel und deren verwendung.
ES2120046T3 (es)	1998-10-16	Procedimiento de preparacion de inmunogenos o reactivos de diagnostico e inmunogenos o reactivos de diagnostico obtenibles por dicho procedimiento.
FI900808A0 (fi)	1990-02-19	Humant mannos bindande protein.
BR9106303A (pt)	1993-04-13	Imonogeno humano composicao,celula de mamifero,peptido,vacina contra sintomas de esclerose multipla,metodo para tratar ou prevenir doenca com sintomas de esclerose multipla e conjunto para diagnosticar esclerose multipla
GR3029774T3 (en)	1999-06-30	Method of preparing a radioactive rhenium complex solution.
ATE244299T1 (de)	2003-07-15	Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
ATE442439T1 (de)	2009-09-15	Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
Mueller et al.	1981	Comparison of vespid venoms collected by electrostimulation and by venom sac extraction
Hill et al.	1994	The effect of immunization of pigs with Ascaris suum cuticle components on the development of resistance to parenteral migration during a challenge infection
NO986218D0 (no)	1998-12-30	FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
NZ328940A (en)	1999-05-28	Methods and use t cell epitopes of lol p v ryegrass pollen antigens
Gelpi et al.	1988	Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins.
Barker et al.	1993	Identification of murine erythrocyte autoantigens and cross-reactive rat antigens
ATE137674T1 (de)	1996-05-15	Von mca 16-88 erkanntes antigen
Reid et al.	1968	Biological and chemical differences among proteins having reaginic activity
King	1996	Immunochemical studies of stinging insect venom allergens
ATE138200T1 (de)	1996-06-15	Das von mca-28a32 erkannte antigen
AR020852A1 (es)	2002-05-29	Antigenos de vacuna de leptospira para la prevencion de leptospirosis
NO900745L (no)	1990-04-06	Humant mannose-bindende protein.